Klinische studies over pulmonale hypertensie

Lopende studies

• COMPERA REGISTER: Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension.
• EXPOSURE Register.
• HYPERION: Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients.
• SOTERIA: An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension Therapy for the Treatment of PAH.
• UNISUS: Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension.
• ADVANCE OUTCOMES: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients (Ralinepag/placebo).
• ADVANCE EXTENSION: A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension.
• PROSERA: A Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of PAH.
• INSIGNIA-PH-COPD: A Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease.

Toekomstige studies

• PHOCUS: A Study to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease.
• PROSERA-EXT: An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PAH).
• C5001001: A Study to Learn How the Study Medicine Called PF-07868489 is Tolerated and Acts in Healthy Adult People and People With Pulmonary Arterial Hypertension.
• CLTP001A12202: A Study to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants with Pulmonary Arterial Hypertension